4.01
3.37%
-0.14
Sutro Biopharma Inc Azioni (STRO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
571.95%
113.72
|
16.92 | 10.41 | 12.67 | 8.632 |
Operating Expenses
|
15.80%
70.57
|
60.94 | 56.59 | 54.91 | 57.85 |
Benefits Costs and Expenses |
3.85%
66.85
|
64.37 | 48.78 | 62.33 | 43.23 |
Costs And Expenses |
3.85%
66.85
|
64.37 | 48.78 | 62.33 | 43.23 |
Operating Income/Loss |
198.04%
43.15
|
-44.01 | -46.18 | -42.24 | -49.22 |
Income/Loss From Continuing Operations Before Tax |
198.79%
46.87
|
-47.45 | -38.37 | -49.66 | -34.59 |
Income Tax Expense/Benefit |
759.54%
15.81
|
1.839 | 0.20 | 0.395 | - |
Income/Loss From Continuing Operations After Tax |
163.03%
31.07
|
-49.28 | -38.52 | -50.05 | -34.59 |
Net Income/Loss
|
163.03%
31.07
|
-49.28 | -38.52 | -50.05 | -34.59 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.56%
0.2694
|
60.60 | 60.34 | 58.72 | 2.1169 |
Diluted Average Shares |
99.56%
0.2694
|
60.60 | 60.34 | 58.72 | 2.1169 |
Basic Earnings Per Share |
164.20%
0.52
|
-0.81 | -0.64 | -0.85 | -0.61 |
Diluted Earnings Per Share |
164.20%
0.52
|
-0.81 | -0.64 | -0.85 | -0.61 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):